Artur C. Fassoni, Christoph Baldow, Ingo Roeder, Ingmar Glauche. Reduced tyrosine kinase inhibitor dose is predicted to be as effective as standard dose in chronic myeloid leukemia: a simulation study based on phase III trial data. Haematologica 2018;103(11):1825-1834; https://doi.org/10.3324/haematol.2018.194522.